+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review

Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative drugs for treating patients suffering from pain. It develops products based on its DETERx platform technology. DETERx offers extended-release drug delivery, while protecting against common methods of abuse and tampering. The company's lead product, Xtampza ER is designed to provide adequate pain control. Its other products include Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy, and Nucynta IR for the management of acute pain severe enough to require an opioid analgesic. The company is headquartered in Stoughton, Massachusetts, the US.

Collegium Pharmaceutical Inc Key Recent Developments

  • Apr 29, 2024: Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA for Nucynta and Nucynta ER
  • Feb 22, 2024: Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
  • Jan 03, 2024: Collegium Provides 2024 Financial Guidance
  • Aug 28, 2023: Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Collegium Pharmaceutical Inc - Key Facts
  • Collegium Pharmaceutical Inc - Key Employees
  • Collegium Pharmaceutical Inc - Key Employee Biographies
  • Collegium Pharmaceutical Inc - Major Products and Services
  • Collegium Pharmaceutical Inc - History
  • Collegium Pharmaceutical Inc - Company Statement
  • Collegium Pharmaceutical Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Collegium Pharmaceutical Inc - Business Description
  • R&D Overview
  • Collegium Pharmaceutical Inc - Corporate Strategy
  • Collegium Pharmaceutical Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Collegium Pharmaceutical Inc - Strengths
  • Collegium Pharmaceutical Inc - Weaknesses
  • Collegium Pharmaceutical Inc - Opportunities
  • Collegium Pharmaceutical Inc - Threats
  • Collegium Pharmaceutical Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Collegium Pharmaceutical Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 29, 2024: Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA for Nucynta and Nucynta ER
  • Feb 22, 2024: Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
  • Jan 03, 2024: Collegium Provides 2024 Financial Guidance
  • Aug 28, 2023: Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
  • Aug 03, 2023: Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
  • May 04, 2023: Collegium Reports First Quarter 2023 Financial Results
  • Feb 23, 2023: Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
  • Feb 06, 2023: Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
  • Jan 04, 2023: Collegium Provides 2023 Financial Guidance
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Collegium Pharmaceutical Inc, Key Facts
  • Collegium Pharmaceutical Inc, Key Employees
  • Collegium Pharmaceutical Inc, Key Employee Biographies
  • Collegium Pharmaceutical Inc, Major Products and Services
  • Collegium Pharmaceutical Inc, History
  • Collegium Pharmaceutical Inc, Subsidiaries
  • Collegium Pharmaceutical Inc, Key Competitors
  • Collegium Pharmaceutical Inc, Ratios based on current share price
  • Collegium Pharmaceutical Inc, Annual Ratios
  • Collegium Pharmaceutical Inc, Interim Ratios
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Collegium Pharmaceutical Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Collegium Pharmaceutical Inc, Performance Chart (2019 - 2023)
  • Collegium Pharmaceutical Inc, Ratio Charts
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Societal CDMO Inc
  • Mallinckrodt Plc
  • Shionogi Inc
  • Purdue Pharma LP
  • Cassava Sciences Inc
  • Elite Pharmaceuticals Inc
  • Acura Pharmaceuticals Inc